Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • 1,2-Dioleoyl-sn-glycero-3-PE (DOPE): Lipid Metabolism, Ferro

    2026-07-31

    1,2-Dioleoyl-sn-glycero-3-PE (DOPE): Lipid Metabolism, Ferroptosis, and Fungal Pathogenicity

    Introduction

    The phospholipid 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) has emerged as a critical component in advanced biotechnological applications, notably as a helper lipid in cationic liposome formulations for nucleic acid delivery. While its role in enhancing transfection efficiency is well recognized, recent breakthroughs have revealed a deeper significance: DOPE’s participation in lipid metabolism pathways that intersect with ferroptotic cell death and fungal pathogenicity. This article delves into the mechanistic, functional, and translational aspects of DOPE, positioning it at the interface of lipid engineering and fungal molecular biology, and offering a perspective distinct from earlier application-focused reviews.

    DOPE as a Helper Lipid: Biophysical and Functional Properties

    DOPE is a zwitterionic phosphatidylethanolamine characterized by unsaturated oleoyl chains, conferring unique fusogenic properties. In lipid nanoparticle (LNP) systems, DOPE’s propensity for non-bilayer (hexagonal II) phase formation under acidic conditions—such as those in endosomes—facilitates membrane destabilization and fusion. This property is essential for the efficient cytoplasmic release of encapsulated nucleic acids, directly enhancing transfection outcomes. According to the product information, DOPE achieves ≥98% purity and can be solubilized at concentrations ≥2.28 mg/mL in DMSO with gentle warming or ≥4.25 mg/mL in ethanol under ultrasonic treatment, but it is insoluble in water, making it suitable for hydrophobic phase integration in nanoparticle assembly.

    Protocol Parameters

    • DOPE dissolution in DMSO: Achieve ≥2.28 mg/mL with gentle warming and ultrasonic treatment.
    • DOPE dissolution in ethanol: Achieve ≥4.25 mg/mL using ultrasonic treatment.
    • Recommended storage: Store solid DOPE at -20°C; use prepared solutions promptly to prevent degradation.
    • Lipid formulation pairing: Combine DOPE with cationic lipids (e.g., DOTAP) and DSPE-PEG for optimal LNP structure and stability.

    Mechanism of Action: Linking DOPE, Lipid Metabolism, and Ferroptosis

    The innovative significance of DOPE extends beyond its textbook function as a membrane fusion enhancer. Recent studies in plant pathology, particularly those investigating Magnaporthe oryzae—the agent of rice blast disease—have illuminated DOPE’s role in modulating ferroptotic cell death, a specialized form of programmed cell death driven by iron-dependent lipid peroxidation.

    In the seminal open-access study by Ma et al. (2026), researchers demonstrated that indole-3-acetic acid (IAA), a fungal-derived auxin, stimulates iron accumulation and lipid peroxidation, culminating in ferroptosis of fungal conidia during pathogenic development. Strikingly, mutants deficient in IAA biosynthesis or lipid metabolism genes (such as tam1Δ or ppoaΔ) exhibited impaired cell death and pathogenicity. Exogenous supplementation with phosphatidylethanolamines—including DOPE—partially restored these defects, underscoring the lipid’s pivotal role in this cell death pathway. This evidence establishes that DOPE’s impact is not limited to delivery vehicles in mammalian cells, but is also instrumental in fungal cell fate decisions and disease progression (Ma et al., 2026).

    Reference Insight Extraction: The Practical Implications of Ma et al. (2026)

    The most profound innovation from Ma et al. (2026) is the demonstration that DOPE and other phosphatidylethanolamines can rescue defective ferroptotic conidial death in fungal mutants lacking either IAA biosynthesis or key lipid metabolism enzymes. This finding reveals a direct, actionable link between lipid composition and cell death mechanisms in fungal biology—an insight that is critical for researchers designing assays or developing antifungal strategies. For practical assay development, it suggests that modulating the levels or availability of DOPE in experimental systems can directly influence ferroptotic outcomes, making DOPE a valuable tool not only for nucleic acid delivery but also for dissecting the molecular underpinnings of cell death and pathogenicity in fungi.

    Comparative Analysis: How This Perspective Differs from Existing Literature

    Previous reviews and workflows have focused on optimizing nucleic acid delivery using DOPE in mammalian systems, emphasizing its role as a helper lipid for high-efficiency transfection. While these resources offer practical guidance on formulation strategies and troubleshooting, they do not address DOPE’s involvement in the unique intersection of auxin signaling, lipid peroxidation, and ferroptotic cell death.

    Other recent articles, such as the PUFA-PL biosynthesis studies, elucidate the importance of fatty acid desaturases in generating polyunsaturated phospholipids required for ferroptosis in Magnaporthe oryzae. However, these works primarily map the genetic and enzymatic landscape, rather than offering a translational bridge to lipid engineering or practical assay modulation using exogenous lipids like DOPE.

    This article, therefore, fills a critical gap by integrating the mechanistic findings from fungal pathogenesis research with the actionable properties of DOPE as a nucleic acid delivery lipid and a modulator of cell fate in fungal systems. By doing so, it provides both a deeper biochemical understanding and practical guidance for researchers straddling the fields of nanomedicine, plant pathology, and antifungal drug development.

    Advanced Applications: Beyond Transfection—DOPE in Antifungal Strategies

    The identification of DOPE as a functional lipid in ferroptotic pathways opens novel avenues for antifungal strategy development. In fungal pathogens like M. oryzae, the balance between lipid peroxidation and antioxidant defense determines the success of infection. By supplementing or modulating helper lipids such as DOPE, it becomes possible to experimentally manipulate ferroptotic cell death, potentially attenuating pathogenicity or sensitizing fungi to chemical inhibitors. This extends DOPE’s relevance far beyond its established role in in vitro transfection reagent lipid systems or genetic vaccine carrier lipids.

    Moreover, this cross-domain insight aligns with the recent focus on developing advanced lipid nanoparticle engineering strategies. While those articles highlight DOPE’s contribution to nanoparticle performance and nucleic acid release, our current perspective uniquely emphasizes DOPE’s ability to modulate programmed cell death in fungal cells. This dual relevance positions DOPE as both a delivery vector and an experimental lever in dissecting lipid-driven cell death mechanisms.

    Why this cross-domain matters, maturity, and limitations

    Bridging mammalian lipid delivery systems and fungal cell death pathways is more than a theoretical exercise. The molecular conservation of ferroptosis and lipid peroxidation across kingdoms suggests that learnings from fungal systems can inform mammalian pathobiology and vice versa. However, the translational maturity of this approach is still emerging; while exogenous DOPE clearly impacts fungal ferroptosis in controlled assays, the complexity of in planta or in vivo interactions and the full spectrum of lipid signaling in disease ecology require further clarification. Researchers should therefore treat DOPE as a powerful probe but not a standalone solution for antifungal therapy development at this stage.

    Protocol Parameters: Workflow Recommendations

    • For nucleic acid delivery: Formulate LNPs with DOPE, cationic lipids, and DSPE-PEG; optimize the DOPE:lipid ratio based on cargo and cell type.
    • For fungal ferroptosis assays: Use exogenous DOPE to rescue or modulate cell death phenotypes in lipid metabolism or auxin signaling mutants, as established in the Ma et al. (2026) study.
    • For storage and handling: Minimize freeze-thaw cycles and prepare DOPE-containing solutions immediately prior to use to maintain functional integrity.

    Conclusion and Future Outlook

    1,2-Dioleoyl-sn-glycero-3-PE (DOPE) occupies a unique nexus in biotechnology, serving as both a lipid nanoparticle formulation lipid for nucleic acid delivery and a pivotal actor in lipid peroxidation-driven ferroptosis in fungi. The insights from Ma et al. (2026) highlight how exogenous DOPE can modulate cell death and pathogenicity, offering new experimental tools and therapeutic targets in plant-microbe interactions. Future research should focus on refining the mechanistic understanding of DOPE’s integration into complex lipid metabolic networks, its potential for anti-tumor nanomedicine lipid component development, and its broader implications for cross-kingdom cell death regulation.

    For researchers and developers seeking high-quality DOPE, APExBIO provides rigorously characterized and application-ready material, ensuring experimental reproducibility and confidence in both advanced delivery and cell death studies.